Bar Admissions

  • Maryland
  • New York

Court Admissions

  • U.S. District Court for the District of Maryland
  • U.S. Court of Appeals for the Fourth Circuit

Education

  • J.D., cum laude, University of Baltimore School of Law, 1998

    Editorial Board, University of Baltimore Law Review, 1997-1998

  • B.A., Villanova University, 1993

Memberships

  • American Bar Association

    International Association of Defense Counsel
T +1 410.244.7553
F +1 410.244.7742
 

Jason C. Rose

Partner

Jason Rose is an experienced litigator who focuses on the efficient resolution of disputes in such areas as pharmaceutical and medical device litigation, business torts, and commercial contracts. He is the co-chair of Venable's Product Liability and Mass Torts practice group.

Jason offers Venable's clients unique business experience based on time he spent working in the international legal group of a leading, global heavy machinery manufacturer while living in Tokyo, Japan. In that capacity he counseled the company's business and legal departments on a variety of risk management issues related to large-scale international industrial projects and ventures. Before joining Venable, Jason also worked in a New York firm, where he represented a major air carrier in the 9/11 Commission investigation and related September 11 litigation arising out of the terrorist attacks in 2001.

REPRESENTATIVE EXPERIENCE

With regard to pharmaceutical product liability litigation, Jason has represented a number of companies in different capacities ranging from case and budget management, to expert witness development, to briefing substantive and Daubert issues, to company story development, to fact and expert depositions, to trial support:
  • Serving as deputy co-national counsel in an MDL and consolidated state court litigation involving proton pump inhibitor drugs.
  • Managing a team of Venable lawyers as national counsel in nationwide litigation involving an anti-epileptic drug.
  • Worked with a team of Venable lawyers as national counsel to a pharmaceutical manufacturer in nationwide litigation involving a drug for Parkinson’s disease.
  • Helped lead a team of lawyers responsible for expert witness development, and a team of Venable lawyers responsible for dispositive and expert-related briefing and multiple trials, in nationwide litigation involving a diabetes drug.
  • Helped lead a team of lawyers responsible for expert witness development in an MDL and consolidated state court litigation involving a hypertension drug.

In commercial litigation, Jason has represented a large real estate investment trust in shareholder litigation over a merger, an insurer in coverage litigation involving a variety of underlying securities transaction, a telemarketing company in arbitration over a marketing services contract dispute, a software company in the confirmation and collection of an arbitration award, and the creditors of a bankrupt energy corporation in a suit over complex derivative transactions.

Activities

Jason is a member of the International Association of Defense Counsel and serves as chair of the Drug, Device & Biotechnology Committee.